LoginSignup
Chugai Pharm logo

Chugai Pharm

Stock
Stock
ISIN: JP3519400000
Ticker: 4519
JP3519400000
4519

Price

Price

Historical dividends and forecast

All dividend data

Chugai Pharm has so far distributed $0.547 in 2024. The next dividend will be paid on 29.03.2025

$0.347

CHART BY

Frequently asked questions

What is Chugai Pharm's market capitalization?

The market capitalization of Chugai Pharm is $69.47B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Chugai Pharm's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Chugai Pharm is 27.15. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Chugai Pharm?

Chugai Pharm's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.524. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Chugai Pharm's stock?

Currently, 11 analysts cover Chugai Pharm's stock, with a consensus target price of $39.95. Analyst ratings provide insights into the stock's expected performance.

What is Chugai Pharm's revenue over the trailing twelve months?

Over the trailing twelve months, Chugai Pharm reported a revenue of $7.40B.

What is the EBITDA for Chugai Pharm?

Chugai Pharm's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.50B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Chugai Pharm?

Chugai Pharm has a free cash flow of $1.39B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Chugai Pharm's stock?

The 5-year beta for Chugai Pharm is 0.88. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Chugai Pharm have, and what sector and industry does it belong to?

Chugai Pharm employs approximately 7,604 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Chugai Pharm's shares?

The free float of Chugai Pharm is 639.56M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $69.47B

5Y beta

 0.88

EPS (TTM)

 $1.524

Free Float

 639.56M

P/E ratio (TTM)

 27.15

Revenue (TTM)

 $7.40B

EBITDA (TTM)

 $3.50B

Free Cashflow (TTM)

 $1.39B

Pricing

1D span
$40.22$40.89
52W span
$26.31$47.96

Analyst Ratings

The price target is $39.95 and the stock is covered by 11 analysts.

Buy

7

Hold

4

Sell

0

Information

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

7,604

Biotechnology & Drugs

Health Care

Identifier

ISIN

JP3519400000

Primary Ticker

4519

Knockouts

Join the conversation
Sign upLogin